Technology licensing office managers often need to evaluate profitability and commercial potential in their decision making. However, increased consideration of important global public health goals requires forging new collaborative relationships, incorporating creative licensing practices and embracing global public good within the academic and research communities. The authors conducted a survey to identify and document opportunities and barriers in the management of discoveries and inventions arising from global health research outcomes at US and Canadian academic and research institutions.
BoettingerS.BennettA. (2005), ‘The Bayh–Dole Act's effects on developing countries: Topics for discussion’, www.merid.org/bayh-dole/.
2.
BrewsterA.L.ChapmanA.R.HansenS.A. (2005), ‘Facilitating humanitarian access to pharmaceutical and agricultural innovation’, Innovation Strategy Today, Vol 1, pp 203–216.
3.
FreireM.C. (2002), ‘Technology transfer's next frontier: Global health as a new bottom line’, Journal of the Association of University Technology Managers, Vol 14, pp 1–5.
4.
GardnerC.GarnerC. (2004), ‘Technology licensing to nontraditional partners: Nonprofit health product development organizations for better global health’, Journal of the Association of University Technology Managers, Vol 16, pp 29–42.
5.
GardnerC.SahaR.SatyanarayanaK. (2004), ‘Building a “cottage industry” for health (and wealth): The new framework for IP management in India’, IP Strategy Today, October, pp 23–58.
6.
GarnerC. (2004), Dealmaking and Intellectual Property Management for Public InterestInitiative on Public–Private Partnerships for Health, Global Forum for Health Research, Geneva, www.globalforumhealth.org/filesupld/ippph/dealmaking.pdf.
7.
KeuschG.T. (2004), ‘Intellectual property and licensing and their impact on global public goods for health options for public sector and academic leadership’, IP Strategy Today, No 10, pp 1–22.
8.
MahoneyR.T., ed (2003), MIHR Handbook of Best Practices for Management of Intellectual Property in Health Research and Development, Centre for the Management of Intellectual Property in Health Research and Development, Oxford.
9.
MerzJ.F. (2005), Intellectual Property and Product Development Public/Private Partnerships, Final Report to the World Health Organization Commission on Intellectual Property Rights, Innovation, and Public Health.
10.
MoranM.A. (2005), ‘A breakthrough in R&D for neglected diseases: New ways to get the drugs we need’, PLoS Medicine, Vol 2, e302.
11.
MorelC.M. (2005), ‘Health innovation networks to help developing countries address neglected diseases,’Science Magazine, Vol 309, No 5733, pp 401–404.
12.
MoweryD.NelsonR.SampatB.ZiedonisA. (2004), Ivory Tower and Industrial Innovation: US University–Industry Technology Transfer Before and After the Bayh–Dole Act, Stanford University Press, Stanford, CA.
13.
NelsenL.L. (2003), ‘The role of universities in assuring access in developing countries’, Yale Journal of Health Policy, Law, and Ethics, Vol 3, pp 301–308.
14.
PunchK.F. (2003), Survey Research: The Basics, Sage, Thousand Oaks, CA.
15.
ThursbyJ.G.ThursbyM.C. (2000), ‘Industry perspectives on licensing university technologies: Sources and problems’, Journal of the Association of University Technology Managers, Vol 12, pp 9–22.
